Impressive boosting of anti-S1/S2 IgG production in COVID-19-experienced patients after the first shot of the BNT162b2 mRNA COVID-19 Vaccine.
Título
Impressive boosting of anti-S1/S2 IgG production in COVID-19-experienced patients after the first shot of the BNT162b2 mRNA COVID-19 Vaccine.
Autor
Amedeo F Capetti, Carlo A Stangalini, Fabio Borgonovo, Davide Mileto, Letizia Oreni, Gianfranco Dedivitiis, Angelica Lupo, Maria V Cossu, Lara Bilardo, Andrea Giacomelli, Massimo Galli, Giuliano Rizzardini
Fecha
2021
Identificador
10.1093/cid/ciab214
Fuente
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Archivos
Colección
Citación
Amedeo F Capetti, Carlo A Stangalini, Fabio Borgonovo, Davide Mileto, Letizia Oreni, Gianfranco Dedivitiis, Angelica Lupo, Maria V Cossu, Lara Bilardo, Andrea Giacomelli, Massimo Galli, Giuliano Rizzardini, “Impressive boosting of anti-S1/S2 IgG production in COVID-19-experienced patients after the first shot of the BNT162b2 mRNA COVID-19 Vaccine.,” SOCICT Open, consulta 19 de abril de 2026, https://socictopen.socict.org/items/show/8674.
Position: 16084 (19 views)